xADAGES III: Contribution of genotype to glaucoma phenotype in African Americans
xADAGES III:基因型对非裔美国人青光眼表型的贡献
基本信息
- 批准号:8559980
- 负责人:
- 金额:$ 157.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-30 至 2018-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAfricanAfrican AmericanAlabamaAmericanAreaBiometryBlindnessCaliforniaCaucasiansCaucasoid RaceClinicalCollaborationsCorneaCustomDNADataData AnalysesData Coordinating CenterData SetDatabase Management SystemsDatabasesDetectionDevelopmentDiagnosisDiagnosticDiseaseDrug TargetingEarEarly InterventionEnrollmentEthnic groupEtiologyEuropeanEvaluation StudiesEyeFamilyFunctional disorderFutureGenesGeneticGenomeGenotypeGlaucomaGoalsInstitutesLarge-Scale SequencingLeadLinkage DisequilibriumLocationMapsMedical GeneticsMedical centerMedicineMeta-AnalysisMethodsMinorityNew YorkOptic NervePathogenesisPathway interactionsPatientsPatternPennsylvaniaPersonsPhenotypePhysiologic Intraocular PressurePopulationPrimary Open Angle GlaucomaPrincipal InvestigatorPrivate PracticeProxyQuality ControlRaceRisk FactorsRunningSamplingSeveritiesSingle Nucleotide PolymorphismStagingStudy SubjectTechnologyTestingThickTimeUniversitiesVariantVisualVisual FieldsVisual impairmentbasecaucasian Americanclinical research sitecohortdesigneffective therapyexomegenetic variantgenome wide association studyhigh riskimprovedinnovationpredictive modelingpublic health relevancerepositorytrait
项目摘要
PROJECT SUMMARY
Glaucoma results in vision loss due to damage of the optic nerve that is irreversible if undetected or
untreated. The most common form of glaucoma is primary open angle glaucoma (POAG). While glaucoma
affects all races, persons of African descent are disproportionately affected; studies show African Americans
(AAs) are about four to five times more likely than Caucasian Americans to develop the disease. Glaucoma is
the leading cause of irreversible blindness in Americans of African descent, and the second leading cause in
all Americans.
The lack of understanding about the etiology of POAG impedes our ability to identify and treat it early in
its development. Evidence of genetic contribution in the pathogenesis of POAG is well established. Since
POAG tends to run in families, it is critical to identify the genetic basis of the disease in order to develop
effective therapies for early intervention.
While genome wide association studies (GWAS) for glaucoma have been completed for Caucasian
populations, evidence from other studies suggests that a GWAS of glaucoma specific genes to the African-
American population will yield unique and important findings for both this population and for glaucoma in
general. A better understanding of the relationship among the stage of disease, the rate of change, ancestry,
and other important risk factors being tracked in the ongoing African Descent and Glaucoma Study (ADAGES)
will allow us to evaluate the relationship between genetics, visual loss and structural damage in this high-risk
cohort.
The scientific plan for this new study focuses on glaucoma in ~2000 African-Americans by detailed
phenotyping of new subjects, acquisition of samples from both new and established previously phenotyped
study subjects for a repository, establishment of a data coordinating center, and genome wide association
studies. The recruitment, enrollment, and phenotyping of both established and new subjects occurs at four
clinical centers, University of California (UCSD), New York Eye and Ear Infirmary New York University of
Medicine, a private practice in the Atlanta area, and the University of Alabama at Birmingham. UCSD is also
the location for the Data Coordinating Center and the Repository with Robert N. Weinreb as Principal
Investigator. CSMC will do the genotyping with a GWAS panel of ~2.5 million single nucleotide polymorphisms
(SNPs) plus an exome set of ~300,000 SNPs using the Illumina Omni2.5 plus exome platform under the
direction of Jerome Rotter and Kent Taylor. CSMC will also provide GWAS and exome data for 3435 controls.
Comparison and confirmation of the GWAS and exome SNPs and data associated with glaucoma will be
compared and confirmed with the University of Pennsylvania's similar glaucoma study.
项目摘要
青光眼由于视神经损伤而导致视力丧失,如果未被发现或
未经治疗。青光眼最常见的形式是原发性开角型青光眼(POAG)。虽然青光眼
影响到所有种族,非洲裔人受到不成比例的影响;研究表明,
(AAs)比白种美国人患上这种疾病的可能性高出四到五倍。青光眼是
非洲裔美国人不可逆转失明的主要原因,
都是美国人
对原发性开角型青光眼病因学的认识不足,阻碍了我们早期识别和治疗该病的能力。
它的发展。遗传因素在原发性开角型青光眼发病机制中的作用已得到充分证实。以来
POAG倾向于在家庭中运行,确定疾病的遗传基础对于发展POAG至关重要。
早期干预的有效疗法。
虽然已经完成了高加索人青光眼的全基因组关联研究(GWAS),
人群中,来自其他研究的证据表明,青光眼特异性基因的GWAS对非洲人,
美国人口将产生独特的和重要的发现,这两个人口和青光眼,
将军更好地理解疾病阶段、变化率、祖先、
正在进行的非洲人后裔和青光眼研究(ADAGES)中跟踪的其他重要风险因素
将使我们能够评估遗传学之间的关系,视力丧失和结构损伤,在这个高风险的,
队列。
这项新研究的科学计划通过详细的方法关注2000名非洲裔美国人的青光眼。
新受试者的表型分析,从新的和已确定的先前表型分析的受试者中采集样本
研究主题为一个知识库,建立一个数据协调中心,和基因组范围内的关联
问题研究已建立和新受试者的招募、入组和表型分型发生在4
临床中心,加州大学(UCSD),纽约眼耳医院,纽约大学
医学,亚特兰大地区的一家私人诊所,以及伯明翰的亚拉巴马大学。UCSD也是
数据协调中心和存储库的位置与罗伯特N。Weinreb作为校长
调查员CSMC将使用约250万个单核苷酸多态性的GWAS组进行基因分型
使用Illumina Omni2.5 plus外显子组平台,在2010年12月25日的第一次测序中,使用约300,000个SNP的外显子组集合,在2010年12月31日的第一次测序中,使用约300,0
方向是杰罗姆罗特和肯特泰勒。CSMC还将提供3435对照的GWAS和外显子组数据。
GWAS和外显子组SNP的比较和确认以及与青光眼相关的数据将在
与宾夕法尼亚大学的类似青光眼研究进行了比较和证实。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jerome I Rotter其他文献
URIDINE MONOPHOSPHATE KINASE: A NEW GENETIC MARKER OF SUSCEPTIBILITY TO HAEMOPHILUS INFLUENZAE TYPE B DISEASE: 158
尿苷单磷酸激酶:B 型流感嗜血杆菌疾病易感性的新遗传标记:158
- DOI:
10.1203/00006450-198507000-00178 - 发表时间:
1985-07-01 - 期刊:
- 影响因子:3.100
- 作者:
Gloria M Petersen;Diana R Silimperi;Edward M Scott;David R Hall;Jerome I Rotter;Joel I Ward - 通讯作者:
Joel I Ward
701 CHROMOSOMAL VARIANTS IN HABITUAL ABORTION
习惯性流产中的 701 种染色体变异
- DOI:
10.1203/00006450-198104001-00724 - 发表时间:
1981-04-01 - 期刊:
- 影响因子:3.100
- 作者:
Bruce D Blumberg;Jeffery D Shulkin;Jerome I Rotter;T K Mohandas;Michael M Kaback - 通讯作者:
Michael M Kaback
Jerome I Rotter的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jerome I Rotter', 18)}}的其他基金
xADAGES III: Contribution of genotype to glaucoma phenotype in African Americans
xADAGES III:基因型对非裔美国人青光眼表型的贡献
- 批准号:
9127971 - 财政年份:2013
- 资助金额:
$ 157.78万 - 项目类别:
xADAGES III: Contribution of genotype to glaucoma phenotype in African Americans
xADAGES III:基因型对非裔美国人青光眼表型的贡献
- 批准号:
8915183 - 财政年份:2013
- 资助金额:
$ 157.78万 - 项目类别:
Mapping Genes for Atherosclerosis and Insulin Resistance
绘制动脉粥样硬化和胰岛素抵抗基因图谱
- 批准号:
7848277 - 财政年份:2007
- 资助金额:
$ 157.78万 - 项目类别:
Mapping Genes for Atherosclerosis and Insulin Resistance
绘制动脉粥样硬化和胰岛素抵抗基因图谱
- 批准号:
7434575 - 财政年份:2007
- 资助金额:
$ 157.78万 - 项目类别:
Mapping Genes for Atherosclerosis and Insulin Resistance
绘制动脉粥样硬化和胰岛素抵抗基因图谱
- 批准号:
7249179 - 财政年份:2007
- 资助金额:
$ 157.78万 - 项目类别:
GENE APPROACH TO IMMUNOPHENOTYPIC SUBGROUPS OF CROHN'S DISEASE
克罗恩病免疫表型亚群的基因方法
- 批准号:
7487325 - 财政年份:2007
- 资助金额:
$ 157.78万 - 项目类别:
Mapping Genes for Atherosclerosis and Insulin Resistance
绘制动脉粥样硬化和胰岛素抵抗基因图谱
- 批准号:
7624596 - 财政年份:2007
- 资助金额:
$ 157.78万 - 项目类别:
GENES AS IMMUNOPHENOTYPIC SUBGROUPS OF CROHN'S DISEASE
基因作为克罗恩病的免疫表型亚群
- 批准号:
7024923 - 财政年份:2005
- 资助金额:
$ 157.78万 - 项目类别:
Genetics of Diabetic Retinopathy in Hispanics
西班牙裔糖尿病视网膜病变的遗传学
- 批准号:
7995175 - 财政年份:2004
- 资助金额:
$ 157.78万 - 项目类别:
Genetics of Diabetic Retinopathy in Hispanics
西班牙裔糖尿病视网膜病变的遗传学
- 批准号:
7909498 - 财政年份:2004
- 资助金额:
$ 157.78万 - 项目类别:
相似海外基金
Broadening Participation Research: Understanding faculty attitudes, competency, and perceptions of providing career advising to African American STEM students at HBCUs
扩大参与研究:了解教师对 HBCU 的非裔美国 STEM 学生提供职业建议的态度、能力和看法
- 批准号:
2306671 - 财政年份:2023
- 资助金额:
$ 157.78万 - 项目类别:
Continuing Grant
Cognitive Behavioral Faith-based Depression Intervention For African American Adults (CB-FAITH): An Effectiveness And Implementation Trial
非裔美国成年人基于认知行为信仰的抑郁干预 (CB-FAITH):有效性和实施试验
- 批准号:
10714464 - 财政年份:2023
- 资助金额:
$ 157.78万 - 项目类别:
DELINEATING THE ROLE OF THE HOMOCYSTEINE-FOLATE-THYMIDYLATE SYNTHASE AXIS AND URACIL ACCUMULATION IN AFRICAN AMERICAN PROSTATE TUMORS
描述同型半胱氨酸-叶酸-胸苷酸合成酶轴和尿嘧啶积累在非裔美国人前列腺肿瘤中的作用
- 批准号:
10723833 - 财政年份:2023
- 资助金额:
$ 157.78万 - 项目类别:
Preventing Firearm Suicide Deaths Among Black/African American Adults
防止黑人/非裔美国成年人因枪支自杀死亡
- 批准号:
10811498 - 财政年份:2023
- 资助金额:
$ 157.78万 - 项目类别:
Exploring PTSD Symptoms, Barriers and Facilitators to Mindfulness-based Stress Reduction for Justice-Involved Black/African American Female Adolescents and Parents/Caregivers
探索创伤后应激障碍 (PTSD) 症状、障碍和促进因素,为涉及正义的黑人/非裔美国女性青少年和父母/照顾者进行基于正念的减压
- 批准号:
10593806 - 财政年份:2023
- 资助金额:
$ 157.78万 - 项目类别:
BCSER - PVEST: A Dynamic Framework for Investigating STEM Interest, Attitude and Identity Among African American Middle School Students
BCSER - PVEST:调查非裔美国中学生 STEM 兴趣、态度和身份的动态框架
- 批准号:
2327055 - 财政年份:2023
- 资助金额:
$ 157.78万 - 项目类别:
Standard Grant
Making the Connection: Understanding the dynamic social connections impacting type 2 diabetes management among Black/African American men
建立联系:了解影响黑人/非裔美国男性 2 型糖尿病管理的动态社会联系
- 批准号:
10782674 - 财政年份:2023
- 资助金额:
$ 157.78万 - 项目类别:
Building a Community-Based Mental Health Literacy Intervention for African American Young Adults
为非裔美国年轻人建立基于社区的心理健康素养干预措施
- 批准号:
10738855 - 财政年份:2023
- 资助金额:
$ 157.78万 - 项目类别:
African American Literature in "post" Post-Racial America
“后”后种族美国中的非裔美国文学
- 批准号:
23K00376 - 财政年份:2023
- 资助金额:
$ 157.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Impact of a Race-Based Stress Reduction Intervention on Well-Being, Inflammation, and DNA methylation in Older African American Women at Risk for Cardiometabolic Disease
基于种族的减压干预措施对有心血管代谢疾病风险的老年非洲裔美国女性的健康、炎症和 DNA 甲基化的影响
- 批准号:
10633624 - 财政年份:2023
- 资助金额:
$ 157.78万 - 项目类别: